Meis1–3, Pbx1–3, and Hoxa9 are upregulated in thymoma, pancreatic adenocarcinoma, glioma, glioblastoma, and leukemia/lymphoma when compared to healthy tissue. This evidence concerns the gene HOXA9 and central nervous system cancer.